UHS

Business Context and Reporting Period

Company: Universal Health Services, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 2004
Business Overview: The Company owns and operates acute care hospitals, behavioral health centers, and ambulatory surgery and radiation oncology centers. As of September 30, 2004, it operated 44 acute care hospitals and 49 behavioral health centers across 23 U.S. states, Washington D.C., Puerto Rico, and France.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Net revenues increased 16% year-over-year for both the three-month and nine-month periods. This was driven by a 4% increase in same-facility revenues and significant contributions from acquisitions ($106 million in Q3; $302 million in YTD).
• Profitability Decline: Despite revenue growth, Net Income decreased 23% in Q3 ($37.8M vs. $49.1M) and 13% YTD ($132.3M vs. $152.8M). Income before taxes dropped $9.8M in Q3 and $31.4M YTD.
• Expense Pressures: The provision for doubtful accounts increased significantly (8.1% of revenue in Q3 2004 vs. 7.0% in Q3 2003) due to a higher volume of uninsured and self-pay patients. Salaries and wages also rose as a percentage of revenue.
• Discontinued Operations: The Company sold several under-performing assets and facilities for approximately $81 million in cash proceeds during the nine months ended September 30, 2004. Discontinued operations resulted in a net loss of $0.9 million in Q3 2004 compared to a gain of $4.4 million in Q3 2003.
• Acquisitions: The Company spent approximately $147 million on acquisitions in the first nine months of 2004, including acute care facilities in Louisiana and France, and behavioral health facilities in Connecticut, Georgia, Arkansas, Nevada, and Kentucky.

Outlook, Risks, and Contingencies

• Guidance: The filing does not provide specific numerical guidance for the full year 2004. Management expects to spend approximately $225 million on capital expenditures for the full year.
• Legal Proceedings:
  • Securities Litigation: Two class action lawsuits and one derivative suit are pending, alleging violations of the Exchange Act and breaches of fiduciary duty. The Company denies the allegations and intends to dismiss them.
  • Patient Billing Lawsuits: Class actions have been filed in Nevada and South Carolina alleging the Company charged higher fees to uninsured patients than insured patients. The Company believes these claims lack merit.
• Insurance and Liability: Due to rising commercial insurance costs, the Company is self-insured for malpractice exposure up to $25 million per occurrence. Total accrual for professional and general liability claims was $194.0 million ($164.5 million net) as of September 30, 2004.
• Market Risks: Management cites risks including unfavorable reimbursement trends from Medicare/Medicaid, increasing uninsured patient volumes, and competition from physician-owned facilities.
• Unusual Items: A $2.3 million pre-tax charge was recorded in Q3 2004 for property damage to a Florida hospital caused by a hurricane, which was not covered by insurance due to deductibles.

Investor Verification Checklist

• Provision for Doubtful Accounts: Verify the trend in bad debt expense relative to revenue, as this metric has increased significantly due to the rise in uninsured patients.
• Discontinued Operations: Confirm the final tax implications and cash proceeds from the sale of the California, Louisiana, and Puerto Rico facilities.
• Legal Exposure: Monitor the status of the securities class action and the derivative suit, as well as the patient billing lawsuits, for potential settlement costs or judgments.
• Self-Insurance Reserves: Review the adequacy of the $194 million liability reserve for professional and general liability claims given the uncertainty of future claim trends.
• Acquisition Integration: Assess the financial performance of the $147 million in new acquisitions, particularly the acute care facilities in Louisiana and France, to ensure they meet profitability targets.